In 2024, "MIP Pharma Latvija" SIA had revenue of 41.6 thousand EUR and profit of 20.6 thousand EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 41,6k € -6.3% | 44,4k € +16.2% | 38,2k € +48.1% |
Profit | 20,6k € +13.6% | 18,1k € +39.9% | 12,9k € +8965.8% |
Assets | 17,2k € -38.3% | 27,9k € -24.1% | 36,8k € +2048.9% |
Liabilities | 243,9k € -11.4% | 275,2k € -8.9% | 302,2k € +7.9% |
Equity | -226,7k € +8.3% | -247,3k € +6.8% | -265,4k € +4.7% |
Employees | 0 | 0 | 0 |
Overall rating | B68/100 |
Financial health | 45/100 |
Credit history | 80/100 |
Legal history | 100/100 |
Business activity | 50/100 |
| Overall risk | Medium |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | Independently |
"MIP Pharma Latvija" SIA is located at Rīga, Kronvalda bulvāris 3 - 1, LV-1010.
In 2024, "MIP Pharma Latvija" SIA had revenue of 41 639 EUR and profit of 20 572 EUR. Compared to previous year, revenue decreased by 6.3%. View full financial report →
Yes, "MIP Pharma Latvija" SIA is registered as an active VAT payer with VAT number LV40103290945.
"MIP Pharma Latvija" SIA was founded on May 11, 2010. The company has been operating for 16 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 16 years | 100 - 104 | 65% | |
Net revenue | 41 639,00 € | 126 - 130 | 50% | |
Profit | 20 572,00 € | 67 - 71 | 76% | |
Equity | -226 688,00 € | - | 10% | |
Assets | 17 225,00 € | 159 - 163 | 40% | |
Liquidity | 0.07 | - | 10% | |
Profitability | 49.4% | - | 90% | |
Registered capital | 2828,00 € | - | 50% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights |
|---|---|---|
| MIP Pharma GmbH | 101 | 100.00% |